Trial intelligence / Profile preview

Lutrepatch for Ovulation Induction in Infertility

NCT00796289Phase 2Completed

Sponsor
Ferring Pharmaceuticals
Start
Feb 2009
Primary completion
Dec 2009
Modality
Peptides, Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of Lutrepatch in infertility, sponsored by Ferring Pharmaceuticals. Started Feb 2009; status: completed.

02

Drugs

Lutrepatch
03

Conditions

infertility

Beyond the preview

Go deeper on NCT00796289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00796289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call